Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease
This study has been completed.
Study NCT00528242   Information provided by Surface Logix
First Received: September 11, 2007   Last Updated: December 17, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Raynaud's Disease
Additional conditions recognized in this trial
Raynaud Disease
More general conditions related to this trial
Cardiovascular Diseases
Peripheral Vascular Diseases
Vascular Diseases
Interventions listed in this trial
SLx-2101
Sponsors listed in this trial
Surface Logix


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services